BIOMARIN PHARMACEUTICAL INC Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
BIOMARIN PHARMACEUTICAL INC (BMRN) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $385.79 million as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Notes › Investments › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2018-02-26
- 2017-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $385.79M.
- 2017-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $416.30M.
- 2017-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $482.04M.
- 2017-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $533.63M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2017-12-31 | $385.79M 10-K · filed 2018-02-26 |
| 2017-09-30 | $416.30M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $482.04M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $533.63M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $572.71M 10-K · filed 2018-02-26 |
| 2016-09-30 | $362.96M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $201.62M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $314.40M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $425.65M 10-K · filed 2017-02-27 |
| 2015-09-30 | $514.38M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $509.63M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $223.92M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $97.86M 10-K · filed 2016-02-29 |
| 2014-09-30 | $448.33M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $244.15M 10-Q · filed 2014-07-31 |
| 2013-12-31 | $267.70M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |